BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9151145)

  • 1. Molecular clues to pathogenesis in prion diseases.
    Laurent M; Johannin G
    Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmissible spongiform encephalopathies.
    Liemann S; Glockshuber R
    Biochem Biophys Res Commun; 1998 Sep; 250(2):187-93. PubMed ID: 9753605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell culture models of transmissible spongiform encephalopathies.
    Béranger F; Mangé A; Solassol J; Lehmann S
    Biochem Biophys Res Commun; 2001 Nov; 289(2):311-6. PubMed ID: 11716473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free formation of protease-resistant prion protein.
    Kocisko DA; Come JH; Priola SA; Chesebro B; Raymond GJ; Lansbury PT; Caughey B
    Nature; 1994 Aug; 370(6489):471-4. PubMed ID: 7913989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards cellular receptors for prions.
    Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
    Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The state of the prion.
    Weissmann C
    Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prion biology: update].
    Weber EL
    Rev Argent Microbiol; 1999; 31(4):205-18. PubMed ID: 10615684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein glycosylation.
    Lawson VA; Collins SJ; Masters CL; Hill AF
    J Neurochem; 2005 May; 93(4):793-801. PubMed ID: 15857383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia and prion disease: a review.
    Brown DR; Kretzschmar HA
    Histol Histopathol; 1997 Jul; 12(3):883-92. PubMed ID: 9225170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prion protein].
    Lehmann S
    J Soc Biol; 2002; 196(4):309-12. PubMed ID: 12645301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
    Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unconventional transmissible agents and prion protein: is something still missing?].
    Laplanche JL
    Ann Biol Clin (Paris); 1997; 55(5):395-407. PubMed ID: 9347006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human prion diseases: molecular and clinical aspects.
    Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
    Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transmissible spongiform encephalopathies (prion diseases)--molecular principles and in vitro models].
    Kretzschmar H
    Wien Med Wochenschr; 1998; 148(4):67-73. PubMed ID: 9611345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.